Voya Investment Management LLC Seres Therapeutics, Inc. Transaction History

Voya Investment Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.75 - $1.56 $5,603 - $11,654	-7,471 Reduced 18.43%	33,061 $25,000
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $4,054 - $8,821	1,740 Added 4.49%	40,532 $96,000
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $52,318 - $73,379	11,203 Added 40.61%	38,792 $185,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $1,523 - $2,891	253 Added 0.93%	27,589 $230,000
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $61,785 - $81,532	3,347 Added 13.95%	27,336 $652,000
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $8,423 - $13,794	477 Added 2.03%	23,989 $494,000
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $129,851 - $210,722	5,585 Added 31.15%	23,512 $576,000
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $8,803 - $67,653	2,354 Added 15.12%	17,927 $508,000
Q2 2020 Aug 14, 2020	SELL	$3.04 - $6.2 $11,266 - $22,977	-3,706 Reduced 19.22%	15,573 $74,000
Q4 2019 Feb 14, 2020	BUY	$2.99 - $4.42 $16,770 - $24,791	5,609 Added 41.03%	19,279 $67,000
Q3 2019 Nov 14, 2019	BUY	$2.29 - $4.16 $8,140 - $14,788	3,555 Added 35.15%	13,670 $55,000
Q3 2017 Nov 14, 2017	BUY	$12.81 - $16.85 $129,573 - $170,437	10,115	10,115 $162,000

46.7M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.